Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Fleming

Showing results (691-700 of 760) with videos related to

Pageof 76
Sort By:
Journal of Physical Activity & Health|October 9, 2019
Supports and Barriers to Home-Based Physical Activity During Preoperative Treatment of Pancreatic Cancer: A Mixed-Methods StudyNathan H Parker, Rebecca E Lee, Daniel P O'Connor, et al.
Annals of Surgical Oncology|February 18, 2010
Serum CA 19-9 as a marker of resectability and survival in patients with potentially resectable pancreatic cancer treated with neoadjuvant chemoradiationMatthew H G Katz, Gauri R Varadhachary, Jason B Fleming, et al.
Cancer Research Communications|December 5, 2023
Discovery of KRB-456, a KRAS G12D Switch-I/II Allosteric Pocket Binder That Inhibits the Growth of Pancreatic Cancer Patient-derived TumorsAslamuzzaman Kazi, Alok Ranjan, Vasantha Kumar M V, et al.
Cancers|January 11, 2024
Pancreatic Cyst Size Measurement on Magnetic Resonance Imaging Compared to PathologyDaniel Jeong, Brian Morse, Stuart Lane Polk, et al.
Nature|March 29, 2013
Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathwayJaekyoung Son, Costas A Lyssiotis, Haoqiang Ying, et al.
Journal of the American College of Surgeons|September 19, 2017
Multi-Institution Analysis of Infection Control Practices Identifies the Subset Associated with Best Surgical Site Infection Performance: A Texas Alliance for Surgical Quality Collaborative ProjectCatherine H Davis, Lillian S Kao, Jason B Fleming, et al.
Cancer|June 1, 2016
Impact of hypofractionated and standard fractionated chemoradiation before pancreatoduodenectomy for pancreatic ductal adenocarcinomaJordan M Cloyd, Christopher H Crane, Eugene J Koay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 30, 2016
Transforming Growth Factor-β Limits Secretion of Lumican by Activated Stellate Cells within Primary Pancreatic Adenocarcinoma TumorsYa'an Kang, David Roife, Yeonju Lee, et al.
Gastroenterology|August 3, 2011
Identification of cancer stem cells in human gastrointestinal carcinoid and neuroendocrine tumorsPuja Gaur, Eric L Sceusi, Shaija Samuel, et al.
JCI Insight|July 24, 2019
Mitochondrial fusion exploits a therapeutic vulnerability of pancreatic cancerMeifang Yu, Nicholas D Nguyen, Yanqing Huang, et al.
Pageof 76

Showing results (691-700 of 760) with videos related to

Sort By:
Pageof 76
Journal of Physical Activity & Health|October 9, 2019
Supports and Barriers to Home-Based Physical Activity During Preoperative Treatment of Pancreatic Cancer: A Mixed-Methods StudyNathan H Parker, Rebecca E Lee, Daniel P O'Connor, et al.
Annals of Surgical Oncology|February 18, 2010
Serum CA 19-9 as a marker of resectability and survival in patients with potentially resectable pancreatic cancer treated with neoadjuvant chemoradiationMatthew H G Katz, Gauri R Varadhachary, Jason B Fleming, et al.
Cancer Research Communications|December 5, 2023
Discovery of KRB-456, a KRAS G12D Switch-I/II Allosteric Pocket Binder That Inhibits the Growth of Pancreatic Cancer Patient-derived TumorsAslamuzzaman Kazi, Alok Ranjan, Vasantha Kumar M V, et al.
Cancers|January 11, 2024
Pancreatic Cyst Size Measurement on Magnetic Resonance Imaging Compared to PathologyDaniel Jeong, Brian Morse, Stuart Lane Polk, et al.
Nature|March 29, 2013
Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathwayJaekyoung Son, Costas A Lyssiotis, Haoqiang Ying, et al.
Journal of the American College of Surgeons|September 19, 2017
Multi-Institution Analysis of Infection Control Practices Identifies the Subset Associated with Best Surgical Site Infection Performance: A Texas Alliance for Surgical Quality Collaborative ProjectCatherine H Davis, Lillian S Kao, Jason B Fleming, et al.
Cancer|June 1, 2016
Impact of hypofractionated and standard fractionated chemoradiation before pancreatoduodenectomy for pancreatic ductal adenocarcinomaJordan M Cloyd, Christopher H Crane, Eugene J Koay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 30, 2016
Transforming Growth Factor-β Limits Secretion of Lumican by Activated Stellate Cells within Primary Pancreatic Adenocarcinoma TumorsYa'an Kang, David Roife, Yeonju Lee, et al.
Gastroenterology|August 3, 2011
Identification of cancer stem cells in human gastrointestinal carcinoid and neuroendocrine tumorsPuja Gaur, Eric L Sceusi, Shaija Samuel, et al.
JCI Insight|July 24, 2019
Mitochondrial fusion exploits a therapeutic vulnerability of pancreatic cancerMeifang Yu, Nicholas D Nguyen, Yanqing Huang, et al.
Pageof 76